Related Experiment Video
Updated: Aug 9, 2026
09:39
Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
Polymer-based biodegradable drug delivery systems in pain management
Mohamed Al Malyan1, Chiara Becchi, Lila Nikkola
1Department of Medical and Surgical Critical Care, Section of Anaesthesia and Intensive Care, Florence University, Florence, Italy.
The Journal of Craniofacial Surgery
|April 25, 2006
Summary
Biodegradable controlled-release devices offer improved pain management by enhancing drug delivery and reducing side effects. This technology shows promise for more effective pain control strategies.
Area of Science:
- Biomedical Engineering
- Pharmacology
- Materials Science
Background:
- Pain affects 21.5% of the global population, causing significant economic losses and immune/metabolic disturbances.
- Current pain management is hindered by modest drug efficacy, severe side effects, and conventional administration limitations.
- Biodegradable controlled-release devices represent a novel approach to address these challenges in pain therapy.
Purpose of the Study:
- To review the scope and fundamentals of pain as a public health issue.
- To provide an overview of biodegradable polymers utilized in drug delivery systems for pain management.
- To summarize existing research on these systems and present novel multimodal drug delivery device development.
Main Methods:
- Literature review of pain management and biodegradable polymer drug delivery systems.
- Analysis of studies focusing on controlled-release devices for pain control.
- Description of a developed multimodal drug delivery device incorporating nanotechnology.
Main Results:
- Biodegradable controlled-release devices improve drug delivery and patient compliance, reducing side effects.
- These devices offer a promising avenue for localized and sustained drug administration in pain management.
- The developed multimodal device demonstrates potential for advanced pain treatment strategies.
Conclusions:
- Biodegradable controlled-release devices are crucial for advancing pain management strategies.
- Further development and application of these technologies, including nanotechnology, are essential for effective pain control.
- This technology enhances drug efficacy and patient outcomes in pain therapy.
Related Concept Videos
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:11Oral Drug Delivery Systems: Delayed-Release Systems
Delayed-release drug delivery systems are specialized pharmaceutical formulations designed to postpone the release of active compounds until the drug reaches a specific region of the gastrointestinal (GI) tract, typically the intestine. These systems are essential for drugs that may cause gastric irritation, are unstable in acidic environments, or need to exert therapeutic effects locally in the intestinal or colonic regions.The core feature of delayed-release systems is the use of enteric...
01:23Modified-Release Drug Delivery Systems: Classification
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:22Modified-Release Drug Delivery Systems: Rate-Programmed I
Rate-programmed drug delivery systems (DDS) are designed to release drugs at specific, controlled rates to maintain consistent therapeutic levels. These systems are categorized based on their release mechanisms, including dissolution-controlled DDS, diffusion-controlled DDS, and combined dissolution-diffusion-controlled DDS.In dissolution-controlled DDS, the release rate depends on the slow dissolution of the drug itself or the surrounding matrix. Drugs with inherently slow dissolution rates,...